Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease

Author(s):  
Verughese Jacob ◽  
Jeffrey A. Reynolds ◽  
Sajal K. Chattopadhyay ◽  
David P. Hopkins ◽  
Nicole L. Therrien ◽  
...  
mHealth ◽  
2018 ◽  
Vol 4 ◽  
pp. 1-1 ◽  
Author(s):  
Saki Fujita ◽  
Isaree Pitaktong ◽  
Graeme Vosit Steller ◽  
Victor Dadfar ◽  
Qinwen Huang ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Hai-Yan Xu ◽  
Yong-Ju Yu ◽  
Qian-Hui Zhang ◽  
Hou-Yuan Hu ◽  
Min Li

Over the past half-century, medical research on cardiovascular disease (CVD) has achieved a great deal; however, medication adherence is unsatisfactory. Nearly 50% of patients do not follow prescriptions when taking medications, which limits the ability to maximize their therapeutic effects and results in adverse clinical outcomes and high healthcare costs. Furthermore, the effects of medication adherence interventions are disappointing, and tailored interventions have been proposed as an appropriate way to improve medication adherence. To rethink and reconstruct methods of improving medication adherence for CVD, the literature on tailored interventions for medication adherence focusing on CVD within the last 5 years is retrieved and reviewed. Focusing on identifying nonadherent patients, detecting barriers to medication adherence, delivering clinical interventions, and constructing theories, this article reviews the present state of tailored interventions for medication adherence in CVD and also rethinks the present difficulties and suggests avenues for future development.


2003 ◽  
Vol 6 (3) ◽  
pp. 191
Author(s):  
KS Chen ◽  
RS Leslie ◽  
E Chang ◽  
C Fairchild

BMJ ◽  
2021 ◽  
pp. n1493
Author(s):  
Steven T Simon ◽  
Vinay Kini ◽  
Andrew E Levy ◽  
P Michael Ho

AbstractCardiovascular disease is the leading cause of death globally. While pharmacological advancements have improved the morbidity and mortality associated with cardiovascular disease, non-adherence to prescribed treatment remains a significant barrier to improved patient outcomes. A variety of strategies to improve medication adherence have been tested in clinical trials, and include the following categories: improving patient education, implementing medication reminders, testing cognitive behavioral interventions, reducing medication costs, utilizing healthcare team members, and streamlining medication dosing regimens. In this review, we describe specific trials within each of these categories and highlight the impact of each on medication adherence. We also examine ongoing trials and future lines of inquiry for improving medication adherence in patients with cardiovascular diseases.


Sign in / Sign up

Export Citation Format

Share Document